Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type I diabetes

Diabetes Care

Volumn 27, Issue 6, 2004, Pages 1259-1264

  McCarter, Robert J ^a,b   Hempe, James M ^c,d   Gomez, Ricardo ^c   Chalew, Stuart A ^c,d  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BIOLOGICAL VARIATION; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCATION; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; MICROVASCULATURE; MULTIPLE REGRESSION; OBSERVER VARIATION; PREDICTION; VASCULAR DISEASE; BLOOD; LONGITUDINAL STUDY; METABOLISM; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL; TIME;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; TIME FACTORS;

EID: 2542426036     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.6.1259     Document Type: Article

References (29)

1. Service FJ, O'Brien PC: The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetologia 44:1215-1220, 2001
2. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in IDDM. N Engl J Med 329: 977-983, 1993
3. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A: Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 295:417-420, 1976
4. Svendsen PA, Lauritzen T, Soegaard U, Nerup J: Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes. Diabetologia 23:403-405, 1982
5. DCCT Research Group: Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 10:1-19, 1987
6. Service FJ: Correlation between glycemia and glycated hemoglobin. Compr Ther 16: 33-40, 1990
7. Fraser CG: Biological Variation: From Principles to Practice. Washington, DC, AACC Press, 2001, p. 151
8. Kilpatrick ES, Maylor PW, Keevil BG: Biological variation of glycated hemoglobin: implications for diabetes screening and monitoring. Diabetes Care 21:261-264, 1998
9. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D: Biological variation of glycohemoglobin. Clin Chem 48:1116-1118, 2002
10. 1c levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 50:2858-2863, 2001
11. Modan M, Meytes D, Rozeman P, Yosef SB, Sehayek E, Yosef NB, Lusky A, Halkin H: Significance of high HbA1 levels in normal glucose tolerance. Diabetes Care 11:422-428, 1988
12. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ: Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33:208-215, 1990
13. Gould BJ, Davie SJ, Yudkin JS: Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 260:49-64, 1997
14. Madsen H, Kjaergaard JJ, Ditzel J: Relationship between glycosylation of haemoglobin and the duration of diabetes: a study during the third trimester of pregnancy. Diabetologia 22:37-40, 1982
15. 1c results in type 1 diabetes. Ann Clin Biochem 36:451-459, 1999
16. Hempe J, Gomez R, McCarter R, Chalew S: High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 16:313-320, 2002
17. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41:202-208, 1992
18. Vitelli LL, Shahar E, Heiss G, McGovern PG, Brancati FL, Eckfeldt JH: Glycosylated hemoglobin level and carotid intimal-medial thickening in non-diabetic individuals. Diabetes Care 20:1454-1458, 1997
19. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322:15-18, 2001
20. 1c and fructosamine. Diabetes Care 26:163-167, 2003
21. DCCT Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47:1703-1720, 1995
22. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
23. DCCT Research Group: Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. Clin Chem 33:2267-2271, 1987
24. Akaike H: Fitting autoregressive models for prediction. Annals of the Institute of Statistical Mathematics 21:243-247, 1969
25. StataCorp: Stata Statistical Software: Release 6.0. Vol. 3. College Station, TX, Stata, 1999, p. 606
26. 1c affected by glycemic instability? Diabetes Care 26:2728-2733, 2003
27. King GL, Brownlee M: The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25:255-270, 1996
28. Rendell M, Stephen PM, Paulsen R, Valentine JL, Rasbold K, Hestorff T, Eastberg S, Shint DC: An interspecies comparison of normal levels of glycosylated hemoglobin and glycosylated albumin. Comp Biochem Physiol B 81:819-822, 1985
29. Szwergold BS, Howell SK, Beisswenger PJ: Intracellular nonenzymatic glycation of hemoglobin in human erythrocytes is controlled by enzymatic deglycation mechanisms (Abstract). Diabetes 53 (Suppl. 1):A815, 2003